loadpatents
name:-0.02678394317627
name:-0.020991086959839
name:-0.0053122043609619
Methot; Joey L. Patent Filings

Methot; Joey L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Methot; Joey L..The latest application filed is for "indazolyl-spiro[2.2]pentane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof".

Company Profile
5.28.33
  • Methot; Joey L. - Westwood MA
  • METHOT; Joey L. - Boston MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Purine inhibitors of human phosphatidylinositol 3-kinase delta
Grant 11,230,547 - McGowan , et al. January 25, 2
2022-01-25
Purine inhibitors of human phosphatidylinositol 3-kinase delta
Grant 11,179,389 - McGowan , et al. November 23, 2
2021-11-23
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
Grant 11,174,248 - Acton , et al. November 16, 2
2021-11-16
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
Grant 11,161,854 - Candito , et al. November 2, 2
2021-11-02
Indazolyl-spiro[2.2]pentane-carbonitrile Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof
App 20210188863 - Candito; David Annunziato ;   et al.
2021-06-24
Indazolyl-spiro[2.3]hexane-carbonitrile Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof
App 20210188818 - Acton; John ;   et al.
2021-06-24
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20200392144 - McGowan; Meredeth A. ;   et al.
2020-12-17
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20200390760 - McGowan; Meredeth A. ;   et al.
2020-12-17
Purine inhibitors of human phosphatidylinositol 3-kinase delta
Grant 10,544,147 - Achab , et al. Ja
2020-01-28
Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta
App 20190119278 - Achab; Abdelghani Abe ;   et al.
2019-04-25
Purine inhibitors of human phosphatidylinositol 3-kinase delta
Grant 10,221,178 - McGowan , et al.
2019-03-05
Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta
App 20180141947 - McGowan; Meredith Ann ;   et al.
2018-05-24
Purine inhibitors of human phosphatidylinositol 3-kinase delta
Grant 9,938,281 - Achab , et al. April 10, 2
2018-04-10
Purine inhibitors of human phosphatidylinositol 3-kinase delta
Grant 9,730,940 - Achab , et al. August 15, 2
2017-08-15
Quinoxalines and AZA-quinoxalines as CRTH.sub.2 receptor modulators
Grant 9,469,615 - Boyce , et al. October 18, 2
2016-10-18
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20160207926 - Achab; Abdelghani Abe ;   et al.
2016-07-21
Quinolines and aza-quinolines as CRTH.sub.2 receptor modulators
Grant 9,290,453 - Boyce , et al. March 22, 2
2016-03-22
Compounds that are ERK inhibitors
Grant 9,233,979 - Wilson , et al. January 12, 2
2016-01-12
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20150353552 - Achab; Abdelghani Abe ;   et al.
2015-12-10
Amidopyrazole inhibitors of interleukin receptor-associated kinases
Grant 9,169,260 - McElroy , et al. October 27, 2
2015-10-27
Novel Compounds That Are Erk Inhibitors
App 20150266895 - Wilson; Kevin J. ;   et al.
2015-09-24
Compounds that are ERK inhibitors
Grant 9,023,865 - Lim , et al. May 5, 2
2015-05-05
Indole derivatives as CRTH2 receptor antagonists
Grant 9,023,864 - Berthelette , et al. May 5, 2
2015-05-05
Quinazolinone-type compounds as CRTH.sub.2 antagonists
Grant 8,927,559 - Aslanian , et al. January 6, 2
2015-01-06
Diaryl ether derivatives as notch sparing gamma secretase inhibitors
Grant 8,871,796 - Brown , et al. October 28, 2
2014-10-28
Novel Compounds That Are Erk Inhibitors
App 20140296203 - Lim; Jongwon ;   et al.
2014-10-02
Amidopyrazole Inhibitors Of Interleukin Receptor-associated Kinases
App 20140194404 - McElroy; William T. ;   et al.
2014-07-10
Spirocyclic compounds
Grant 8,686,020 - Hamblett , et al. April 1, 2
2014-04-01
Quinoxalines And Aza-quinoxalines As Crth2 Receptor Modulators
App 20130303517 - Boyce; Christopher W. ;   et al.
2013-11-14
Quinolines And Aza-quinolines As Crth2 Receptor Modulators
App 20130296300 - Boyce; Christopher W. ;   et al.
2013-11-07
Quinazolinone-type Compounds As Crth2 Antagonists
App 20130210805 - Aslanian; Robert G. ;   et al.
2013-08-15
Indole Derivatives as CRTH2 Receptor Antagonists
App 20130150398 - Berthelette; Carl ;   et al.
2013-06-13
Spirocyclic Compounds
App 20130131041 - Berk; Scott C. ;   et al.
2013-05-23
Diaryl Ether Derivatives As Notch Sparing Gamma Secretase Inhibitors
App 20130053386 - Brown; William Colby ;   et al.
2013-02-28
Spirocyclic compounds
Grant 8,349,825 - Mampreian , et al. January 8, 2
2013-01-08
Silicon Derivatives As Histone Deacetylase Inhibitors
App 20110130361 - Grimm; Jonathan ;   et al.
2011-06-02
Spirocyclic Compounds
App 20110098268 - Mampreian; Dawn M. ;   et al.
2011-04-28
Spirocyclic compounds
Grant 7,834,026 - Berk , et al. November 16, 2
2010-11-16
Spirocyclic Compounds
App 20090209566 - Berk; Scott C. ;   et al.
2009-08-20
Spirocyclic compounds
Grant 7,544,695 - Berk , et al. June 9, 2
2009-06-09
Substituted Nicotinamide Compounds
App 20090105264 - Hamblett; Christopher ;   et al.
2009-04-23
Benzothiophene derivatives
App 20090082308 - Hubbs; Jed Lee ;   et al.
2009-03-26
Spirocyclic compounds
App 20070117824 - Berk; Scott C. ;   et al.
2007-05-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed